Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Surgery
Published in: BMC Surgery 1/2018

Open Access 01-12-2018 | Research article

Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis

Authors: Zhiyong Dong, Sheikh Mohammed Shariful Islam, Ashley M. Yu, Rui Qu, Bingsheng Guan, Junchang Zhang, Zhao Hong, Cunchuang Wang

Published in: BMC Surgery | Issue 1/2018

Login to get access

Abstract

Background

Laparoscopic metabolic surgery has been previously shown to be an effective treatment for obese patients with type 2 diabetes (T2DM). The objective of this scoping review is to determine the impact of metabolic surgery for the treatment of type 2 diabetes in Asia and perform an evidence-based analysis.

Methods

We performed a literature search in PubMed for research on laparoscopic metabolic surgery for the treatment of T2DM in Asia region. We classified the included studies based on the Oxford Center for Evidence Based Medicine guidelines. And performed and evidence analysis.

Results

In total, 205 articles were identified. 62.9% of the studies were from East Asia. The evidence of 26 studies are level I, 59 are level II. Laparoscopic sleeve gastrectomy (LSG) was the most commonly reported surgical procedure (63.1%) in Asia. The number of laparoscopic metabolic surgery for T2DM in Asian countries has increased rapidly over the last 8 years. We identified 16 studies which showed that laparoscopic metabolic surgery is an effective and safe treatment for T2DM in patients with a BMI of > 25 kg/m2 to < 35 kg/m2 in Asia.

Conclusions

Our results suggest that laparoscopic metabolic surgery might be an effective and safe treatment for T2DM patients with BMI < 35 kg/m2, and that LSG is the most commonly performed surgical procedure for this in Asia.
Literature
1.
Islam SM, Purnat TD, Phuong NT, Mwingira U, Schacht K, Fröschl G. Non-communicable diseases (NCDs) in developing countries: a symposium report. Global Health. 2014;10:81.CrossRef
2.
3.
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81.CrossRef
4.
Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–32.CrossRef
5.
Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159(12):1150–9.CrossRef
6.
Dobbins M, Decorby K, Choi BC. The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med. 2013;2013:680536.CrossRef
7.
Chan RS, Woo J. Prevention of overweight and obesity: how effective is the current public health approach. Int J Environ Res Public Health. 2010;7(3):765–83.CrossRef
8.
Islam SMS, Lechner A, Ferrari U, et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Global Health. 2017;2(1):e000033.CrossRef
9.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-Centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.CrossRef
10.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.CrossRef
11.
Yan Y, Sha Y, Yao G, et al. Roux-en-Y gastric bypass versus medical treatment for type 2 diabetes mellitus in obese patients: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(17):e3462.CrossRef
12.
Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7.CrossRef
13.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50 discussion 50-2.CrossRef
14.
Kalyvas AV, Hughes M, Koutsarnakis C, et al. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir. 2017;159(1):33–49.CrossRef
15.
Skubleny D, Switzer NJ, Gill RS, et al. The impact of bariatric surgery on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Surg. 2016;26(1):169–76.CrossRef
16.
Nagendran M, Carlin AM, Bacal D, et al. Self-reported remission of obstructive sleep apnea following bariatric surgery: cohort study. Surg Obes Relat Dis. 2015;11(3):697–703.CrossRef
17.
Wu GZ, Cai B, Yu F, et al. Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget. 2016;7(52):87511–22.PubMedPubMedCentral
18.
Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI < 35 kg/m2. Diabetes Care. 2016;39(6):924–33.CrossRef
19.
Kumar N. Weight loss endoscopy: development, applications, and current status. World J Gastroenterol. 2016;22(31):7069–79.CrossRef
20.
Umemura A, Lee WJ, Sasaki A, Wakabayashi G. History and current status of bariatric and metabolic surgeries in East Asia. Asian J Endosc Surg. 2015;8(3):268–74.CrossRef
21.
22.
23.
Du X, Zhou HX, Zhang SQ, Tian HM, Zhou ZG, Cheng Z. A comparative study of the metabolic effects of LSG and LRYGB in Chinese diabetes patients with BMI < 35 kg/m2. Surg Obes Relat Dis. 2017;13(2):189–97.CrossRef
24.
Di J, Zhang H, Yu H, Zhang P, Wang Z, Jia W. Effect of roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m2. Surg Obes Relat Dis. 2016;12(7):1357–63.CrossRef
25.
Gong K, Li K, Zhang N, et al. Gastric bypass procedure for type 2 diabetes patients with BMI < 28 kg/m2. Surg Endosc. 2017;31(3):1172–9.CrossRef
26.
Kular KS, Manchanda N, Cheema GK. Seven years of mini-gastric bypass in type II diabetes patients with a body mass index < 35 kg/m(2). Obes Surg. 2016;26(7):1457–62.CrossRef
27.
Li J, Xie G, Tian Q, Hu Y, Meng Q, Zhang M. Laparoscopic jejunoileal side-to-side anastomosis for the treatment of type 2 diabetes mellitus in Chinese patients with a body mass index of 24–32 kg/m2. J Cancer Res Ther. 2016;12(Supplement):5–10.
28.
Yang J, Wang C, Cao G, et al. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2). BMC Surg. 2015;15:88.CrossRef
29.
Yi B, Jiang J, Zhu L, Li P, Im I, Zhu S. Comparison of the effects of roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI < 35 kg/m(2). Surg Obes Relat Dis. 2015;11(5):1061–8.CrossRef
30.
Kim MJ, Hur KY. Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (< 30 kg/m(2)) patients. Obes Surg. 2014;24(7):1044–51.CrossRef
31.
Shrestha C, He H, Liu Y, Zhu S, Xiong J, Mo Z. Changes in Adipokines following laparoscopic roux-en-Y gastric bypass surgery in Chinese individuals with type 2 diabetes mellitus and BMI of 22-30 kg.M(−2.). Int. J Endocrinol. 2013;2013:240971.
32.
Lakdawala M, Shaikh S, Bandukwala S, Remedios C, Shah M, Bhasker AG. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2013;9(3):370–8.CrossRef
33.
Wu Q, Xiao Z, Cheng Z, Tian H. Changes of blood glucose and gastrointestinal hormones 4 months after roux-en-Y gastric bypass surgery in Chinese obese type 2 diabetes patients with lower body mass index. J Diabetes Investig. 2013;4(2):214–21.CrossRef
34.
Zhu L, Mo Z, Yang X, et al. Effect of laparoscopic roux-en-Y gastroenterostomy with BMI<35 kg/m(2) in type 2 diabetes mellitus. Obes Surg. 2012;22(10):1562–7.CrossRef
35.
Huang CK, Shabbir A, Lo CH, Tai CM, Chen YS, Houng JY. Laparoscopic roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg. 2011;21(9):1344–9.CrossRef
36.
Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index < 35 kg/m2. Obes Surg. 2011;21(7):889–95.CrossRef
37.
Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index < 35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332–8.CrossRef
38.
Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and < 35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.CrossRef
39.
Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673–89.CrossRef
40.
Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.CrossRef
41.
Kim MK, Lee WY, Kang JH, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29(4):405–9.CrossRef
42.
Lee WJ, Aung L. Metabolic surgery for type 2 diabetes mellitus: experience from Asia. Diabetes Metab J. 2016;40(6):433–43.CrossRef
43.
(NGC). NGC. Guideline summary: Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. In: National Guideline Clearinghouse (NGC) [Website] Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013. Available: https://​www.​guideline.​gov. Accessed 19 Nov 2017.
44.
45.
46.
El Chaar M, Hammoud N, Ezeji G, Claros L, Miletics M, Stoltzfus J. Laparoscopic sleeve gastrectomy versus laparoscopic roux-en-Y gastric bypass: a single center experience with 2 years follow-up. Obes Surg. 2015;25(2):254–62.CrossRef
47.
Biter LU, van Buuren MMA, Mannaerts GHH, et al. Quality of life 1 year after laparoscopic sleeve gastrectomy versus laparoscopic roux-en-Y gastric bypass: a randomized controlled trial focusing on gastroesophageal reflux disease. Obes Surg. 2017;27(10):2557–65.CrossRef
48.
Arabi Basharic F, OlyaeeManesh A, Ranjbar Ezzat Abadi M, Shiryazdi SM, Shabahang H, Jangjoo A. Evaluation of laparoscopic sleeve gastrectomy compared with laparoscopic Roux-en-Y gastric bypass for people with morbid obesity: A systematic review and meta-analysis. Med J Islam Repub Iran. 2016;3:354.
49.
Li JF, Lai DD, Ni B, Sun KX. Comparison of laparoscopic roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg. 2013;56(6):E158–64.CrossRef
50.
Perrone F, Bianciardi E, Ippoliti S, Nardella J, Fabi F, Gentileschi P. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of morbid obesity: a monocentric prospective study with minimum follow-up of 5 years. Updat Surg. 2017;69(1):101–7.CrossRef
51.
Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care. 2010;33(7):1561–6.CrossRef
52.
Tinahones FJ, Queipo-Ortuno MI, Clemente-Postigo M, Fernnadez-Garcia D, Mingrone G, Cardona F. Postprandial hypertriglyceridemia predicts improvement in insulin resistance in obese patients after bariatric surgery. Surg Obes Relat Dis. 2013;9(2):213–8.CrossRef
53.
Li J, Lai D, Wu D. Laparoscopic roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg. 2016;26(2):429–42.CrossRef
54.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77.CrossRef
55.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & bariatric surgery. Surg Obes Relat Dis. 2013;9(2):159–91.CrossRef
56.
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management Algorithm-2017 executive summary. Endocr Pract. 2017;23(2):207–38.CrossRef
57.
Stegenga H, Haines A, Jones K, et al. GUIDELINES identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. Bmj-Brit Med J. 2014;349.CrossRef
58.
Rao WS, Shan CX, Zhang W, Jiang DZ, Qiu M. A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤35 kg/m(2) undergoing roux-en-Y gastric bypass. World J Surg. 2015;39(1):223–30.CrossRef
59.
Yip WCY, Sequeira IR, Plank LD, Poppitt SD. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia. Nutrients. 2017;9(11).CrossRef
60.
Ma RC, Chan JC. Type 2 diabetes in east Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64–91.CrossRef
61.
Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One. 2011;6(6):e19930.CrossRef
Metadata
Title
Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis
Authors
Zhiyong Dong
Sheikh Mohammed Shariful Islam
Ashley M. Yu
Rui Qu
Bingsheng Guan
Junchang Zhang
Zhao Hong
Cunchuang Wang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2018
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-018-0406-3

Other articles of this Issue 1/2018

BMC Surgery 1/2018 Go to the issue

Case report

Complete abdominal wound and anastomotic leak with diffuse peritonitis closure achieved by an abdominal vacuum sealing drainage in a critical ill patient: a case report

Research article

Optimized method to harvest both kidneys from one donor rat for transplantation

Research article

Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma

Case report

Lumbar spine epidural abscess and facet joint septic arthritis due to Streptococcus agalactiae: a case report

Research article

Predictors of postoperative hypocalcemia occurring after a total thyroidectomy: results of prospective multicenter study

Case report

Aortoesophageal fistula and arch pseudoaneurysm after removing of a swallowed chicken bone: a case report of one-stage hybrid treatment